These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1035172

  • 1. New combined oral contraceptive with incremental progestogen dosage regimen.
    Brosens I, Van Assche A, Koninckx P, Heyns W, De Hertogh R.
    Eur J Obstet Gynecol Reprod Biol; 1976; 6(6):315-8. PubMed ID: 1035172
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Sep 15; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 4. The mechanism of action of a new low-dosed combined oral contraceptive.
    Dericks-Tan JS, Schneider K, Taubert HD.
    Arch Gynecol; 1980 Sep 15; 229(2):107-14. PubMed ID: 6768343
    [Abstract] [Full Text] [Related]

  • 5. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations.
    Elstein M, Morris SE, Groom GV, Jenner DA, Scarisbrick JJ, Cameron EH.
    Fertil Steril; 1976 Aug 15; 27(8):892-9. PubMed ID: 955131
    [Abstract] [Full Text] [Related]

  • 6. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH, Schmid R, Spona J.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):601-4. PubMed ID: 6798765
    [Abstract] [Full Text] [Related]

  • 7. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
    Spona J, Feichtinger W, Kindermann C, Moore C, Mellinger U, Walter F, Gräser T.
    Contraception; 1997 Sep 16; 56(3):185-91. PubMed ID: 9347211
    [Abstract] [Full Text] [Related]

  • 8. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 9. The effect of vaginal administration of low-dose oral contraceptive tablets on human ovulation.
    Souka AR, el Sokkary H, Kamel M, Hassan M.
    Contraception; 1986 Apr 01; 33(4):365-71. PubMed ID: 3731776
    [Abstract] [Full Text] [Related]

  • 10. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
    Landgren BM, Diczfalusy E.
    Contraception; 1984 May 01; 29(5):437-46. PubMed ID: 6430642
    [Abstract] [Full Text] [Related]

  • 11. The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis.
    Nuttall ID, Elstein M, Fahmy DR.
    Contraception; 1982 May 01; 25(5):463-9. PubMed ID: 6809424
    [Abstract] [Full Text] [Related]

  • 12. The effect of combined oral contraceptive steroids on the gonadotropin responses to LH-RH in lactating women with regular menstrual cycles resumed.
    Ryu K, Hong SS.
    Contraception; 1983 Jun 01; 27(6):605-17. PubMed ID: 6413131
    [Abstract] [Full Text] [Related]

  • 13. Ovulation inhibition with a combined oral contraceptive containing 20 micrograms ethinyl estradiol and 250 micrograms levonorgestrel. Serum levels of the active ingredients and FSH, LH, estradiol 17-beta and progesterone.
    Lunell NO, Carlström K, Zador G.
    Acta Obstet Gynecol Scand Suppl; 1979 Jun 01; 88():17-21. PubMed ID: 294110
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of incremental dosage regimen of combined oestrogen-progestogen oral contraceptive.
    Brosens IA, Robertson WB, Van Assche FA.
    Br Med J; 1974 Dec 14; 4(5945):643-5. PubMed ID: 4441832
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.